3 recruiting, 1 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Encephalitis Autoimmune: new trials by email Literature Review of Encephalitis Autoimmune trials Research Report on Encephalitis Autoimmune
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efgartigimod in Anti-NMDA Receptor Encephalitis. Efgartigimod Alfa - Encephalitis Autoimmune | Phase 2 | Recruiting | Beijing Tongren Hospital | 20 | 2026-06-25 | 2026-09-16 |
| High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network Blood test - Acute Disseminated Encephalomyelitis, Encephalitis Autoimmune | Not applicable | Recruiting | University Hospital, Angers | 20 | 2025-11-16 | 2026-04-27 |
| Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology Epilepsy, Encephalitis Autoimmune | Recruiting | Shen Chun-Hong | 300 | 2023-08-01 | 2025-08-27 | |
| CASPR2 Encephalitis Initial Symptoms CASPR2 encephalitis - CASPR2-Antibody, Encephalitis Autoimmune | Completed | Hospices Civils de Lyon | 48 | 2021-01-11 | 2022-02-04 |
Autoimmune Diseases of the Nervous System (4) · Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1) · Cortical Dysplasia-Focal Epilepsy Syndrome (1) · Encephalomyelitis, Acute Disseminated (1) · Epilepsy (1) · Paraneoplastic Syndromes (1)
Autoimmune Diseases (4) · Immune System Diseases (4) · Nervous System Diseases (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Neoplasms (2) · Chronic Disease (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Encephalitis (1) · Leukoencephalopathies (1) · Neoplasms by Site (1) · Nervous System Neoplasms (1) · Neurodegenerative Diseases (1)
Hematologic Tests (1) · efgartigimod alfa (1)
Beijing Tongren Hospital (1) · Hospices Civils de Lyon (1) · Shen Chun-Hong (1) · University Hospital, Angers (1)
China (2) · France (2)
Chunhong Shen (1)